New Key Statistics Module, Z-Score and F-Score
OTCPK:IVBIY Key Ratios
| Market Cap $ M | 8,920.12 |
| Enterprise Value $ M | 8,007.58 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 523.81 |
| Price/Book | 5.04 |
| Price/Sales | 8.45 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,035.00 |
| EPS (TTM) $ | -0.45 |
| Beneish M-Score | -2.26 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 40.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -47.63 |
| EV-to-EBITDA | -57.12 |
| PEG | -- |
| Shares Outstanding M | 405.46 |
| Net Margin (%) | -17.25 |
| Operating Margin % | -10.63 |
| Pre-tax Margin (%) | -17.24 |
| Quick Ratio | 2.78 |
| Current Ratio | 3.00 |
| ROA % (ttm) | -6.77 |
| ROE % (ttm) | -11.16 |
| ROIC % (ttm) | -8.26 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.26 |
IVBIY Number of Guru Trades
IVBIY Volume of Guru Trades
Gurus Latest Trades with OTCPK:IVBIY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:IVBIY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Innovent Biologics Inc Insider Transactions
No Available Data
News about OTCPK:IVBIY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers